Medichem International Holdings ltd

Medichem, whose main scope is custom synthesis or manufacturing, contract rewith a R&D institute, a GMP approved factory and three cooperative factories, is specialized in R&D, production and marketing for new APIs and key intermediates.
Business Scope: Custom Synthesis or Manufacturing,
main products:
1. 2-Chloro-3,4-dimethoxybenzaldehyde 2. N-[2-hydroxy-2-(4-methoxyphenyl)ethyl]-2-(2-chloro-3,4-ethoxyphenyl)ethylamine 3. 3-acetylmercapto-2-benzylpropionic acid 4. 2-benzylacrylic acid 5. Glycine benzyl ester toluene-p-sulfonate 6. N-3-[3-(1-Piperidinylmethyl)phenoxy]propylamine

Activity:

- Contract Manufacturing
- Contract Research
- Manufacturing
- Research & Development

Product / Technology type(s) covered:

- API / chemicals
- NCE (new chemical entities)
- Pharmaceuticals / Therapeutics

Therapeutic targets:

- Aging
- AIDS
- Allergy
- Alzheimer's Disease
- Arthritis / Rheumato
- Asthma
- Cancer
- Cardiovascular
- Central nervous system
- Cough / Cold
- Dermatology
- Diabetes
- Epidemiology
- Gastrointestinal
- Geriatrics
- Hematology
- Infectious Diseases
- Men's Health
- Mental Health
- Neurology
- Obesity
- Oncology
- Orthopedics
- Pain
- Pediatrics
- Reproductive Health
- Urology

Markets Covered

a. HeadQuarter: Hong Kong

b. Continent(s) active: Europe , Asia , Central/South America , North America , Australia/New-Zealand

c. Countries active: Corea, Japan, India, Germany, USA

Corporate data:

Number of Employees: 20

Turnover:

Amount:	Year:	Currency:
1,000,000	2002	Yen

Year founded: 2002